Arsenal Capital acquire Cyalume $45 million cash

Arsenal to acquire Cyalume for $45 million cash

10:06 AM, 9th August 2017
Arsenal Capital logo

FORT LAUDERDALE, US: Arsenal Capital Partners (Arsenal) has agreed to acquire Cyalume Technologies Holdings Inc (CYLU), for a total cash consideration of $45 million. The deal is expected to close in September 2017.

Cyalume currently estimates that, if the closing of the transaction were to occur on August 31, 2017, the total amount to be paid to holders of Cyalume’s common stock would be approximately $5.8 million, or approximately $0.2081 per share of common stock.

“We are very pleased to announce this transaction with Arsenal, as we believe it affords us the opportunity to both deliver a return to many of our various stake holders that have supported Cyalume over the past several years and positions the Company for continued growth and future success,” said Zivi Nedivi, Cyalume President and CEO.

“We are very excited to have Arsenal as our partner and we are confident that with their strategic and financial support we will be able to significantly accelerate our growth in the speciality chemical, pharmaceutical and medical product markets,” added Dale Baker, chief operating officer, Cyalume.

“Cyalume has a strong brand and long-term relationships with blue chip customers. Given its robust portfolio of technologies, we expect that Cyalume will serve as a platform for further acquisitions in the speciality chemicals and performance polymers sector. We look forward to partnering with the Cyalume team to expand the Company’s capabilities,” said Sal Gagliardo, industry and operations partner, Arsenal.

“The investment in Cyalume represents an opportunity for Arsenal to leverage its industry knowledge and operating expertise in the formulated materials sector to support the company’s strategy,” added Roy Seroussi, principal at Arsenal.

Greenberg Traurig serves as legal counsel to Cyalume, and Cassel Salpeter & Co LLC acts as financial advisor to the special committee of the board of directors of Cyalume. 

DLA Piper LLP (US) serves as legal counsel to Arsenal Capital Partners in connection with the transaction. 

© Worldofchemicals News 

0 Comments

Login

Your Comments (Up to 2000 characters)
Please respect our community and the integrity of its participants. WOC reserves the right to moderate and approve your comment.

Related News


ICL, Energean ink MOU for long-term supply of natural gas

TEL AVIV, ISRAEL: Israel Chemicals Ltd (ICL) has signed a non-binding memorandum of understanding (MoU) with Energean Israel Limited (Energean) to ent ...

Read more
Mexichem to acquire 80 pc stake in Netafim for $1.5 billion

TLALNEPANTLA, US: Mexichem has reached a definitive agreement to acquire 80 percent stake in Netafim Ltd, a private irrigation company in Israel, for ...

Read more
Researchers finally reveal how birds get their colour

CHICAGO, US: Birds' feathers or plumage, are some of the most amazing variable animal characteristics that can be observed by the naked eye. The patte ...

Read more
Enterprise prices $1.7 bn of junior subordinated notes due 2077

HOUSTON, US: Enterprise Products Partners LP (EPD) said that its operating subsidiary, Enterprise Products Operating LLC (EPO), has priced a public of ...

Read more
Amec Foster bags contract for gas-to-liquid plant in Uzbekistan

LONDON, UK: Amec Foster Wheeler has been awarded a lump sum contract by Hyundai Engineering Co Ltd, for the delivery of hydrogen plant technology and ...

Read more
Fluor bags EPCM contract for Petronas isononanol plant

IRVING, US: Fluor Corporation (FLR) has been awarded an engineering, procurement and construction management (EPCM) contract by Petronas Refinery ...

Read more